Skip to content

BioSig Technologies, Inc. STEX Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Bit Digital logo
Bit DigitalBTBT
StoneX Group Inc. logo
StoneX Group Inc.SNEX
Medtronic logo
MedtronicMDT
ROP
Roper Technologies, Inc.ROP

Other financials

Income statement

See full
Revenue$13.0K+8.3%
Gross profit$12.0K-88.9%
Operating income-$35.7M-1,098%
Net income-$46.7M-1,560%
EPS (diluted)-$0.27-92.9%

Balance sheet

See full
Cash & equivalents$6.9M+84.0%
Total debt$15.0K-94.7%
Total equity$159.0M+6,003%
Total assets$173.3M+3,823%

Cash flow

See full
Operating cash flow-$10.2M-813%
CapEx$4.0K-93.1%
Free cash flow-$2.9M+29.4%

Valuation

See full
Market cap$88.66M-61.8%
P/S2,216.6×-5,967×

Profitability

See full
Gross margin80.1%+25.2pp
Operating margin-32,155%-14,261pp
Net margin-25,825%-11,789pp
FCF margin-97,216.7%-106,293pp

Returns & leverage

See full
Return on equity-627.1%
Debt / equity
Current ratio13.9×+11.5×

Where this comes from

Reported directly by BioSig Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: BioSig Technologies, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioSig Technologies, Inc.'s common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioSig Technologies, Inc.'s common stock, shares, outstanding?
BioSig Technologies, Inc. (STEX) reported common stock, shares, outstanding of $97.72M in Q1 2026.
How has BioSig Technologies, Inc.'s common stock, shares, outstanding changed year-over-year?
BioSig Technologies, Inc.'s common stock, shares, outstanding increased by 303.0% year-over-year, from $24.25M to $97.72M.
What is the long-term trend for BioSig Technologies, Inc.'s common stock, shares, outstanding?
Over 5 years (2020 to 2025), BioSig Technologies, Inc.'s common stock, shares, outstanding has grown at a 10.1% compound annual growth rate (CAGR), from $30.76M to $49.81M.